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Such information would aid in patient selection and
choice of operative technique. Thus the purpose of this
study was to identify factors influencing the durability
of repair for degenerative mitral valve disease.
Patients and methods
Patients
Study group. From 1985 to January 1, 1997, 1072 patients
with mitral regurgitation caused by degenerative disease
underwent isolated primary mitral valve repair at The
Cleveland Clinic Foundation. These were identified as fol-
lows. Initially, the prospective Cardiovascular Information
Registry (CVIR) was used to identify all patients having
surgery for mitral regurgitation. The patients’ medical records
were then reviewed in detail, both to select those having
degenerative disease and to verify the prospectively acquired
CVIR clinical data. The study group was further refined by
excluding patients having concomitant coronary artery, aortic
valve, or arrhythmia (maze) operations. Patients with tricuspid
annuloplasty were retained.
Definition. Degenerative valve disease was considered to be
D egenerative mitral valve disease is the most com-mon cause of mitral regurgitation in the United
States.1-3 With the use of current techniques, up to 95%
of degenerative mitral valves can be repaired.4 Several
large studies confirm high rates of freedom from reop-
eration after mitral valve repair.2-7 However, informa-
tion concerning risk factors for reoperation is scarce.
Background: Degenerative mitral valve disease is the most common cause
of mitral regurgitation in the United States. Mitral valve repair is applic-
able in the majority of these patients and has become the procedure of
choice. Objective: This study was undertaken to identify factors influencing
the durability of mitral valve repair. Patients and methods: Between 1985
and 1997, 1072 patients underwent primary isolated mitral valve repair
for valvular regurgitation caused by degenerative disease. Repair dura-
bility was assessed by multivariable risk factor analysis of reoperation. It
was supplemented by a search for valve-related risk factors for death
before reoperation. Three hospital deaths occurred (0.3%); complete fol-
low-up (4152 patient-years) was available in 1062 of 1069 hospital sur-
vivors (99.3%). Results: At 10 years, freedom from reoperation was 93%.
Among 30 patients who required reoperation for late mitral valve dys-
function, the repair failed in 16 (53%) as a result of progressive degener-
ative disease. Durability of repair was adversely affected by pathologic
conditions other than posterior leaflet prolapse, use of chordal shortening,
annuloplasty alone, and posterior leaflet resection without annuloplasty.
Durability was greatest after quadrangular resection and annuloplasty
for posterior leaflet prolapse and was enhanced by the use of intraopera-
tive echocardiography. Death before reoperation was increased in
patients having isolated anterior leaflet prolapse or valvular calcification
and by use of chordal shortening or annuloplasty alone. Conclusions:
Repair durability is greatest in patients with isolated posterior leaflet pro-
lapse who have posterior leaflet resection and annuloplasty. Chordal short-
ening, annuloplasty alone, and leaflet resection without annuloplasty
jeopardize late results. (J Thorac Cardiovasc Surg 1998;116:734-43)
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present when the patient had mitral regurgitation resulting
from leaflet prolapse or annular dilatation and pathologic find-
ings at operation were consistent with degenerative disease.
The diagnosis of degenerative mitral valve disease was con-
firmed by echocardiographic and surgical findings.
Patient characteristics.  Mean age at repair was 58 ± 12.5
years; 198 patients (18%) were 70 years of age or older. A
total of 699 (65%) were men. Nearly all (96%) had moderate
or severe mitral regurgitation. Eighty-four percent of patients
were in New York Heart Association functional class I or II.
Posterior leaflet prolapse resulting from posterior chordal
rupture was the most common finding, present in nearly half
of the patients (Fig 1). Calcification of the anulus or leaflets
was present in 16% of patients.
Comorbid conditions included atrial fibrillation in 39%,
hypertension in 33%, chronic obstructive pulmonary disease
in 8%, peripheral vascular disease in 5%, and diabetes in 3%.
Follow-up. Systematic CVIR follow-up every 2 years was
supplemented by telephone interview with the patient or refer-
ring cardiologist, or both, for those alive at the time of the pre-
vious anniversary follow-up. Complete follow-up information
was available in 1062 of 1069 hospital survivors (99.3%).
Four patients could not be traced beyond hospital discharge,
and 3 patients had partial follow-up. Mean length of follow-up
among survivors was 4.0 ± 2.9 years, ranging from 2 months
to 11 years. Median follow-up was 3.4 years; 25% were fol-
lowed up for 6 years or more.
Outcomes. Durability of mitral valve repair was assessed
primarily by the event reoperation after valve repair. Sec-
ondarily, we investigated death before reoperation to ascer-
tain whether valve-related factors may have been associated
with some deaths, possibly also reflecting durability of mitral
valve repair. For this event, patients were censored for death
at the time of reoperation.
Other events investigated briefly were all-cause death,
thromboembolism, bleeding, and endocarditis.
Data analysis
Freedom from events. Nonparametric, non-risk-adjusted
estimates of freedom from events were obtained by the
method of Kaplan and Meier.8 For each event, a parametric
method was used to resolve the number of hazard phases,
identify the shape of the hazard function, and estimate its
parameters.9
Multivariable analyses of outcomes. The potential risk fac-
tors (variables) entered into the analysis of reoperation and
death before reoperation are listed in Appendix A.
Exploratory analyses included correlation analysis, contin-
gency table analysis of categoric variables, t test of the con-
tinuous variables, stratified life-table analyses, and decile risk
analysis of ordinal and continuous variables to determine pos-
sible transformations of scale. A directed technique of step-
wise entry of variables into the multivariable risk factor model
was then used.10 The P value criterion for retention of vari-
ables in the final model was .05. Regression coefficients are
presented ±1 standard error.
To better understand the nature of the risk factors, we per-
formed a sequence of 3 analyses for each event. In the first,
all but repair variables were analyzed. In the second, all but
valve pathology variables were examined. In the third, all
variables were examined.
Nature and influence of risk factors. The influence of risk
factors was explored in a risk-adjusted manner by construct-
ing nomograms representing the solution of the parametric
multivariable equation for specific values supplied for each
risk factor, varying only 1 factor of interest.
Competing risks of events. In addition to its secondary use
in searching for possible valve-related risk factors for death
before reoperation, this event was also used to estimate the
proportion of patients likely to require reoperation before
dying. This is commonly called a competing risks analysis in
the biostatistical community and actual versus actuarial
analysis by Grunkemeier and colleagues.11-13 For this analy-
sis, 3 mutually exclusive time-related end-states were defined:
(1) alive without reoperation, (2) dead before reoperation, and
(3) reoperation. The common time interval to each event was
the time to the earliest event. Nonparametric competing risks
estimates used the generalized Kaplan-Meier multiple-decre-
ment method. Parametric risk-adjusted competing risks explo-
rations were performed by means of the multivariable equa-
tions for each event, followed by numeric integration of the
competing risks equations.
Presentation. Asymmetric 68% confidence limits are com-
parable to ±1 standard error. In parametric depictions (smooth
curves), these are represented by dashed lines. Nonparametric
life-table estimates are presented with a symbol at the time of
an event and vertical bars representing asymmetric 68% con-
fidence limits. Periodically across time, the number of patients
at risk are presented within parentheses.
Results
Surgical techniques and operative results. Overall,
88% of patients had an annuloplasty as part of the
repair (Table I). Annuloplasty techniques varied during
the period of this study. Techniques used included
Cosgrove-Edwards annuloplasty band (Baxter Health-
care Corp, Irvine, Calif), Carpentier-Edwards classic
Fig 1. Pathologic anatomy of degenerative mitral valve dis-
ease (n = 1072).
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annuloplasty ring (Baxter Healthcare), and posterior
pericardial plication with autologous pericardium or
Periguard graft (Baxter Healthcare).
The most commonly performed operation was poste-
rior leaflet quadrangular resection and annuloplasty
(375 patients). Other frequent operations were posterior
leaflet quadrangular resection, sliding leaflet repair and
annuloplasty (136 patients), posterior leaflet quadran-
gular resection without annuloplasty (118 patients),
and posterior leaflet quadrangular resection, chordal
transfer, and annuloplasty (52 patients). Twenty-nine
patients had annuloplasty alone. Twelve patients had
concomitant tricuspid valve repair. Other combinations
of mitral valve repair techniques were used in 391
patients. Intraoperative transesophageal echocardiogra-
phy was used in 690 patients.
There were 3 operative deaths. All were attributable
to cardiac failure. Of note, 2 of the 3 patients who died
required a second period of cardiopulmonary bypass
because of residual mitral regurgitation after initial
repair. Postoperative morbidity included re-exploration
for bleeding (47 patients, 4.4%), respiratory insufficiency
(24 patients, 2.2%), myocardial infarction (10 patients,
0.9%), stroke (10 patients, 0.9%), and renal failure (8
patients, 0.7%).
Durability of the repair
Outcome. Thirty patients required late reoperation for
recurrent mitral valve regurgitation. Sixteen of these
(53%) had repair failure because of progression of degen-
erative valve disease (Table II). Thirteen patients (43%)
had reoperation within 1 year. At reoperation, 23 patients
had mitral valve replacement and 7 had re-repair. All
patients who had mitral valve re-repair survived the oper-
ation, and 1 patient undergoing replacement died. All sur-
vivors were in New York Heart Association functional
class I at most recent follow-up.
Non-risk-adjusted freedom from reoperation. Ten-year
freedom from reoperation was 92.9% (CL 91%-94.4%;
Fig 2, A). The competing risks analysis revealed a simi-
lar “actual” freedom from reoperation because the
prevalence of death before reoperation was low. The
instantaneous risk of reoperation (hazard function) con-
Table I. Surgical techniques used for mitral valve
repair
Technique No. %
Annuloplasty 949 88
Cosgrove-Edwards 421 39
Pericardial* 313 29
Carpentier-Edwards 215 20
Posterior leaflet resection 869 81
Posterior sliding repair 231 22
Chordal transfer 226 21
Chordal shortening 98 10
Calcium debridement 72 7
*Posterior pericardial annuloplasty was performed either with Periguard patch
(306 patients) or autologous pericardium (7 patients).
Table II. Causes of failed mitral valve repair
Cause of failed repair (n = 30) No. %
Valve related 17 57
Progressive disease 16 53
Endocarditis 1 3
Procedure related 9 30
Ruptured chordae (previously shortened) 4 13
Suture dehiscence 3 10
Incomplete repair 2 7
Unknown 4 13
Fig 2. A, Freedom from reoperation after mitral valve repair
(nonparametric and parametric estimates; see Patients and
methods for details of the presentation). Note expanded ver-
tical axis. B, Instantaneous risk (hazard function) for reoper-
ation across time after mitral valve repair.
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Table III. Incremental risk factors for reoperation
Hazard phase
Early Late
Risk factor Coefficient ±SD P value Coefficient ±SD P value
Patient
Valve pathology
Prolapse of posterior leaflet* –2.1 ± 0.63 .0006 — —
Repair
Repair of coaptation 3.9 ± 0.65 <.0001 — —
Chordal shortening 1.35 ± 0.64 .04 — —
Ring annuloplasty + leaflet resection* — — –2.1 ± 0.55 .0002
Use of intraoperative echo* — — –1.22 ± 0.53 .02
Intercepts –3.63 –4.87
SD, Standard deviation. Shaping parameter estimates: early phase d = 0, r = 0.386, n = 0, m = –1; late phase t = 1, a = 1, g = 1, h = 1.66.
*Note: The negative sign on the coefficient indicates that the factor lessens the risk of reoperation.
Fig 3. Influence of valve pathology and operative technique on freedom from reoperation. A, Anterior leaflet pro-
lapse versus posterior leaflet prolapse. The presentation is a risk-adjusted comparison using the multivariable
equation for a patient undergoing an operation with resection and annuloplasty without chordal shortening and
using intraoperative echocardiography. B, Chordal shortening versus no chordal shortening. (The presentation is
non-risk-adjusted, showing both nonparametric and parametric estimates.) C, Posterior leaflet resection with
annuloplasty (with or without sliding repair) versus all other repair techniques. D, Use of intraoperative echocar-
diography versus no intraoperative echocardiography.
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sisted of 2 hazard phases (Fig 2, B): There was a peak-
ing early hazard phase in the first year after the operation
followed by a slowly rising late hazard of reoperation.
Factors influencing repair durability. Incremental
risk factors for reoperation differed depending on the
interval between the primary operation and reoperation
(Table III). Valve pathology influenced the risk of reop-
eration only during the early hazard phase. Patients
with isolated anterior leaflet prolapse had an increased
early risk of reoperation when compared with those
with posterior leaflet prolapse (Fig 3, A); however,
after 1 year, the instantaneous risk of valve failure was
similar between patients with anterior leaflet prolapse
and those with posterior leaflet prolapse. Valvular cal-
cification had no impact on the risk of reoperation.
Repair techniques influenced the risk of reoperation
in both the early and late hazard phases. The risk of
early repair failure was increased by chordal shortening
(Fig 3, B) and the requirement for additional sutures in
the valve leaflets to increase leaflet coaptation. When
compared with all other procedures, the technique of
ring annuloplasty and leaflet resection was associated
with decreased risk of reoperation in the late hazard
phase (Fig 3, C).
Correspondingly, the risk of reoperation was increased
in those patients who had chordal procedures without
leaflet resection, annuloplasty alone, or leaflet resection
without annuloplasty. Late durability was enhanced by
intraoperative echocardiography (Fig 3, D).
Death before reoperation
Non-risk-adjusted estimates. Survival without reoper-
ation was 82% (CL 79%-84%) 10 years after repair. The
hazard function for death before reoperation was simi-
lar in pattern to that of reoperation in that 2 hazard phas-
es were resolved, an early rapidly falling hazard that
then rose steadily after the first year (Fig 4, A). These 2
hazard functions generate the risk-unadjusted propor-
tion of patients alive without reoperation, dying before
reoperation, and experiencing reoperation (Fig 4, B).
Factors influencing death before reoperation. Patients
with isolated anterior leaflet prolapse or with valve calci-
fication had an increased risk of death after operation
(Table IV). In addition, patients who had chordal shorten-
ing or annuloplasty alone experienced an increased risk of
late death. Additional factors associated with an increased
risk of death were earlier date of repair, older age, atrial
fibrillation, and renal disease. All had a minor effect on the
estimates of 10-year prevalence of reoperation.
Other outcomes. Overall, there were 67 late deaths.
Forty percent of late deaths were attributable to cardiac
causes and 60% were noncardiac. The risk factors were
identical to those for death before reoperation (Table
IV) and differed trivially in magnitude. A summary of
1, 5, and 10 years’ freedom from all outcomes studied
after mitral valve repair is presented in Table V.
Discussion
Repair durability. Since the introduction of stan-
dardized techniques for mitral valve reconstruction by
Carpentier, Duran, and others, mitral valve repair has
become the surgical treatment of choice for mitral
regurgitation.14-16 Numerous retrospective studies have
demonstrated important benefits of mitral valve repair
over mitral valve replacement.17-19 Mitral valve repair
is most applicable to patients with degenerative mitral
valve disease, with successful valvuloplasty possible in
95% of such patients.2-4 Furthermore, it is in patients
with degenerative mitral valve disease that repair has
its greatest durability. With the longest follow-up to
Fig 4. Death as a competing risk for reoperation. A, Hazard
functions for death and reoperation, which compete to reduce
the number of patients having reoperation. B, Number of
patients (expressed as a percent of total) who remained alive
without reoperation, died before reoperation, and experi-
enced reoperation. The 2 hazard functions depicted in A act
on the group alive without reoperation to populate the 2 out-
come categories. 
The Journal of Thoracic and
Cardiovascular Surgery
Volume 116, Number 5
Gillinov et al   739
date, Deloche and associates4 found that 15-year free-
dom from reoperation after mitral valve repair was
93% in patients with degenerative disease.
Although repair durability is good in patients with
degenerative disease, some patients will require late reop-
eration for recurrent mitral valve dysfunction. Causes of
failed mitral valve repair may be classified as procedure-
related (rupture of previously shortened chordae, suture
dehiscence, incomplete initial operation) or valve-related
(progressive disease, endocarditis). Previous studies have
documented a high proportion of procedure-related repair
failures in patients with degenerative disease.20 This sug-
gests that modification of operative technique might
increase repair durability.
Previously identified risk factors for failure of mitral
valve repair include advanced myxomatous changes of
both leaflets, chordal shortening procedures, failure to
perform an annuloplasty, residual mitral regurgitation at
the completion of repair, New York Heart Association
functional class III or IV, and performance of concomi-
tant cardiac procedures.3,5,20-23 In the current analysis,
both patient-related and surgical factors influenced the
risk of reoperation on the mitral valve. However,
patients with the most common pathologic finding—
posterior leaflet prolapse caused by chordal rupture—
had the lowest risk of late reoperation. Correspondingly,
the “standard” mitral valve repair of posterior leaflet
quadrangular resection and annuloplasty had the greatest
Table IV. Incremental risk factors for death before reoperation
Hazard phase
Early Late
Risk factor Coefficient ±SD P value Coefficient ±SD P value
Patient
Demographic
Older age — — 0.065 ± 0.0162 <.0001
Valve pathology
Isolated anterior leaflet prolapse — — 0.85 ± 0.38 .02
Annular or leaflet calcification — — 0.77 ± 0.29 .008
Comorbidity
Atrial fibrillation — — 0.65 ± 0.31 .03
Renal disease — — 2.1 ± 0.64 .001
Higher blood urea nitrogen 0.052 ± 0.0192 .007 — —
Repair
Chordal shortening — — 0.85 ± 0.31 .006
Annuloplasty alone — — 1.61 ± 0.51 .002
Experience
Earlier date of repair –0.38 ± 0.21 .006 — —
Intercepts –3.61 –10.7
SD, Standard deviation. Shaping parameter estimates: early phase d = 0, r = 0.292, n = 0, m = –1; late phase t = 1, a = 1, g = 1, h = 1.68.
Table V. Events after mitral valve repair
Freedom
1 y 5 y 10 y
Event No At risk (patient-years) % CL % CL % CL
Death (all) 70 4264 98.6 98.2-98.9 93.0 92.1-93.8 81 78-83
Death before operation 66 4152 98.6 98.2-98.9 93.2 92.3-94.0 82 79-84
Reoperation 30 4152 98.7 98.3-99.0 96.9 96.2-97.5 92.9 91.0-94.4
Re-repair 7 4152 99.7 99.5-99.8 99.2 98.8-99.5 98.6 97.9-99.0
Replacement 23 4171 98.7 98.3-99.0 96.9 96.2-97.5 92.9 91.0-94.4
Thromboembolism* 40 4081 98.8 98.4-99.0 96.2 95.4-96.8 88 85-90
Bleeding* 6 4157 99.7 99.4-99.8 99.4 99.0-99.6 99.0 98.4-99.4
Endocarditis* 3 4163 100 99.9-100 99.7 99.4-99.8 98.9 97.9-99.5
In no case was the risk (hazard function) constant across time; thus linearized rates have not been presented.
*Before valve replacement.
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durability. This supports the results of Perier and
coworkers.24 Failure to add an annuloplasty to posterior
leaflet resection increased the risk of late reoperation.
However, the type of annuloplasty (Cosgrove-Edwards,
Carpentier-Edwards, posterior pericardial plication) did
not influence repair durability.
Other specific repair techniques had an impact on
repair durability. As we have demonstrated previously,
chordal shortening increased the risk of late reopera-
tion.20,21 Shortened chordae tend to rupture at the site of
insertion into the papillary muscle trench.21 In addition,
the requirement for additional leaflet sutures to increase
local leaflet coaptation increased the risk of reoperation.
Annuloplasty alone was also associated with a higher risk
of reoperation. Finally, intraoperative echocardiographic
guidance decreased the risk of late reoperation.
Late mortality. Although several studies document
long-term survival after repair of degenerative mitral
valves, most of these series include patients undergoing
concomitant coronary artery bypass grafting.2,3,5,6 The
presence of coronary artery disease may have an impor-
tant impact on late survival, obscuring the “natural his-
tory” after isolated mitral valve repair. Nonetheless, in
such series the 10-year survival is generally about
80%.2,3,5,6 Deloche and colleagues4 reported a 15-year
survival of 71% in patients undergoing primary isolated
mitral valve repair for degenerative disease. In the latter
series, approximately half of late deaths were valve-
related. Similarly, important aortic valve abnormalities
may jeopardize late survival, and we have not included
patients with multiple valve disease in our study.
Previous studies provide little insight into risk fac-
tors for late mortality after mitral valve repair. In our
study, we were particularly interested in exploring the
possibility that risk factors related to the mitral valve
might emerge that could reflect hidden additional
repair failure. Both specific valve disease and specific
surgical techniques increased the risk of death. These
factors were among those that increased the risk of
reoperation. Thus using valve reoperation as the sole
indicator of valve repair durability may underestimate
repair failure.
Limitations. The primary purpose of this study was to
identify factors influencing the durability of mitral valve
repair. We have used mitral reoperation as the primary
indicator of durability. In addition, mitral valve–related
risk factors for late death served as a secondary indica-
tor of durability. Unfortunately, serial echocardiographic
follow-up assessment of mitral valve function was
unavailable in the majority of patients. Therefore the
data did not allow identification of patients who had
recurrent mitral regurgitation but did not undergo reop-
eration, precluding an assessment of durability based on
both reoperation and recurrent mitral regurgitation.
This series excluded, by design, patients with addition-
al cardiac disease. Therefore results of this study may not
be extrapolated to patients undergoing mitral valve repair
in association with treatment of coronary artery disease,
aortic valve disease, or other coexisting conditions.
Inferences concerning repair of degenerated mitral
valves. Our results suggest several conclusions concern-
ing surgical technique for repair of the degenerative mitral
valve. Intraoperative echocardiography should be used
routinely to assess the mechanism of valve dysfunction
and the results of valve repair. Posterior leaflet quadran-
gular resection should be accompanied by an annuloplas-
ty. Anterior leaflet prolapse should be corrected by tech-
niques other than chordal shortening. In this series,
chordal transfer did not increase the risk of repair failure,
and previous studies demonstrate that it is a durable tech-
nique for treatment of anterior leaflet prolapse.21,25,26
Other techniques for correction of anterior leaflet prolapse
might include use of artificial chordae and anchoring the
free edge of the anterior leaflet to the posterior leaflet.27-29
Data comparing these techniques to chordal transfer are
currently unavailable. Therefore we currently favor
chordal transfer for correction of anterior leaflet prolapse.
Conclusions
This study has identified specific risk factors influenc-
ing durability of mitral valve repair for degenerative
mitral regurgitation. The most durable repairs are
obtained in patients with isolated posterior leaflet pro-
lapse; these patients should be treated by quadrangular
leaflet resection and annuloplasty. Chordal shortening
increases the risk of reoperation and late death and
should be supplanted by other techniques to correct ante-
rior leaflet prolapse. Annuloplasty alone should rarely be
used to correct mitral regurgitation in degenerative
valves. Intraoperative echocardiography should be used
routinely to guide repair and assess operative results.
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PhD, and Penny Houghtaling, MS, of the Department of
Biostatistics and Epidemiology, Cleveland Clinic Foundation.
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Appendix A: Variables included in multivariable
analyses of risk factors for death and reoperation
Demography
Age
Sex
Pre-repair studies
New York Heart Association functional class
Chronic heart failure
Emergency surgery
Mitral valve disease
Prolapse of anterior leaflet
Prolapse of posterior leaflet
Rupture of chordae to anterior leaflet
Rupture of chordae to posterior leaflet
Elongation of chordae to anterior leaflet
Elongation of chordae to posterior leaflet
Annular calcification
Leaflet calcification
Annular dilatation
Left ventricular function
Grade of left ventricular dysfunction
History of myocardial infarction
Left ventricular hypertrophy
Cardiac comorbidity
Preoperative atrial fibrillation
Number of coronary systems with greater than 50% stenosis
Family history of coronary artery disease
Noncardiac comorbidity
Diabetes
Hypertension
Cerebrovascular accident
Peripheral vascular disease
Chronic obstructive pulmonary disease
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Renal failure
Blood urea nitrogen
Repair
Date of repair
Use of annuloplasty
Type of annuloplasty
Leaflet resection
Sliding leaflet repair
Chordal transfer (anteroanterior, posteroanterior, 
anteroposterior)
Chordal shortening
Chordal resection
Repair of residual defect in leaflet coaptation
Use of intraoperative echocardiography
Discussion
Dr Lawrence H. Cohn (Boston, Mass). This is an out-
standing paper by one of the premier mitral valve surgical
units in the world. It summarizes an enormous experience,
with superb statistical treatment courtesy of Dr Blackstone.
I agree with a great deal of what you say, particularly with
regard to the annuloplasty ring. The contributions by
Carpentier, Duran, and most recently by Dr Cosgrove of your
institution, where an annuloplasty ring is used, have stan-
dardized and made reproducible the mitral valve repair oper-
ation the world over for floppy valve disease. 
We presented a paper before this Association about 4 years
ago in which we suggested that not using a support ring leads
to a higher dysfunction rate. Your second point in this paper
is that using chordal shortening techniques, particularly the
trench technique in which you incise the papillary muscle and
insert the chordae, leads to a higher dysfunction rate, partic-
ularly for anterior leaflet abnormalities. In 1991 we began to
use the polytetrafluoroethylene* chorda technique, which
was first suggested by Dr David, Dr Frater, Dr Zussa of New
York, and Dr Treviso. In this situation we believe less is
more. I know you used the “flip-over” technique, that is,
using the posterior leaflet for anterior leaflet rupture. I would
like to know what you do if you have a perfectly normal pos-
terior leaflet and purely anterior leaflet prolapse. Do you still
flip over part of the normal leaflet of the mitral posterior
leaflet and use it as the support for the anterior leaflet?
I think the reason the ring is necessary—and every one of
us has gotten a competent valve with complex floppy
valves—is that often the anulus is very distorted and this leads
to further dysfunction. Would you please comment on that
point?
Finally, I would like to mention some of the insights we
have gained in a small experience with the use of polytetra-
fluoroethylene chordae for primarily anterior leaflet disease.
We no longer incise and remove a part of the anterior leaflet;
we would prefer to use polytetrafluoroethylene chordae to
both papillary muscles. In this situation we believe less is
more. It is particularly efficacious in minimally invasive
mitral valve repair.
Dr Gillinov. Thank you for your comments. You noted Dr
Blackstone’s contributions, and I should say that without him
much of this analysis would not have been possible. 
You commented on 2 general repair techniques: first, the
use of a ring annuloplasty to reinforce the repair and remod-
el the anulus. We support this concept. Our results agree with
yours, demonstrating that if a posterior leaflet resection is
done without the use of a ring, the durability of the repair is
jeopardized. Specifically, if posterior leaflet prolapse is treat-
ed with a posterior leaflet resection and ring annuloplasty, the
freedom from reoperation at 10 years is 97%. Failure to use
the ring results in only 90% freedom from reoperation. 
You also raised the question of the treatment of anterior
mitral leaflet prolapse, a challenge that has been met suc-
cessfully over the past 10 years. Currently, our preference is
to use chordal transposition techniques, either transfer of a
chord with a piece of leaflet from the posterior leaflet to the
anterior leaflet or of a secondary anterior leaflet chord to the
unsupported free edge of the anterior leaflet. However, as you
noted, several groups, including yours, have had excellent
experience with polytetrafluoroethylene chordae, and this
might also be a good solution to that problem. We do not
practice anterior leaflet resection. Of note, Alfieri recently
described a technique of attaching the free edge of the anteri-
or leaflet to the posterior leaflet to correct anterior leaflet pro-
lapse. This may be another solution to the problem of anteri-
or leaflet prolapse.
Dr Meredith L. Scott (Orlando, Fla). During this period
of time, what types of rings did you use and what type of
repair technique? In the subset of patients that had the ring
only, did you evaluate left ventricular function or dilated car-
diomyopathy?
Dr Gillinov. During the time period of the study, the type
of ring varied. The first 200 or so patients received a
Carpentier-Edwards ring. Thereafter, about 300 patients had
a posterior pericardial plication of the anulus generally using
a Periguard graft. The last 400 or so patients have had a
Cosgrove-Edwards ring. We analyzed the ring type for its
effect on durability of repair and found no difference in dura-
bility based on annuloplasty type. However, failure to use an
annuloplasty ring did decrease repair durability.
You asked about the patients who had annuloplasty alone as
a repair technique for degenerative disease. This series includ-
ed only 29 such patients. These were not patients with car-
diomyopathy; these were patients who underwent a single
repair technique. In fact, they may have needed a leaflet resec-
tion or addition of other techniques because annuloplasty
alone emerged as a risk factor for late repair failure. 
Dr Tirone E. David (Toronto, Ontario, Canada). I was
intrigued by your findings that anterior leaflet prolapse was
an independent predictor not only of death but also of reop-
eration. It tells me that something has to be done about that.
We have not done as many cases as the Cleveland Clinic sur-
geons, but we have done some 600 cases and we presented
part of our series at this meeting last year. Anterior leaflet
*Gore-Tex tissue; registered trademark of W. L. Gore & Associates,
Inc, Elkton, Md. 
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prolapse was not a predictor of poor outcome in our series. I
think the difference is that we are very liberal users of poly-
tetrafluoroethylene sutures to replace or reinforce any chorda
that does not look right. Even if there is no leaflet prolapse
but a chorda is flimsy, our tendency is to reinforce it with a
fine polytetrafluoroethylene suture. This may explain why
anterior leaflet prolapse did not affect our late results.
Dr Gillinov. Thank you for your comments. That certainly
is a possibility. When we correct anterior leaflet prolapse
using chordal transposition, it is difficult to reinforce the
entire free edge of the anterior leaflet. Perhaps with the cre-
ation of artificial chordae, it is possible to support more areas
of the anterior leaflet and provide better support in certain
instances of diffuse degenerative disease of the anterior
leaflet.
Dr Radu C. Deac (Tirgu-Mures, Romania). In your follow-
up, did you study the orifice area of this mitral valve? Can you
comment on the quality of life after these operations?
Dr Gillinov. I do not have data on the orifice area of the
mitral valve. I can tell you that annular dilatation was the
principal pathologic abnormality in 22% of the patients, but I
do not have echocardiographic data for the entire subset. I
also do not have data on quality of life.
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